Follow-up after treatment of Neisseria gonorrhoeae infections, when and how is a test-of-cure to be included in routine? A prospective observational cohort study

Follow-up after treatment of Neisseria gonorrhoeae infections, when and how is a test-of-cure to be included in routine? A prospective observational cohort study - Test-of-cure for Neisseria gonorrhoeae

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38963

Enrollment

Registered

2013-10-04

Start date

2014-03-10

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gonorrhoea Neisseria gonorrhoeae

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 18 years or older Infection with Neisseria gonorrhoeae of urethra, vagina/cervix and/or anal canal Infection with Neisseria gonorrhoeae diagnosed by Gram-stained smear, APTIMA Combo 2 (NAAT) and/or direct cultivation Willing to receive the routine treatment for Ng

Exclusion criteria

Exclusion criteria: Use of antibiotics one week prior to gonorrhoea treatment Current pregnancy in females Only urethral infection in females Ng infections diagnosed by Gram-stained smear, but subsequently not confirmed by NAAT or cultivation.

Design outcomes

Secondary

Measure	Time frame
Secondary endpoints are clearance per anatomical location and intermittent presence of bacterial DNA and/or RNA.	—

Primary

Measure	Time frame
The primary endpoints are clearance of Ng infection and time to clearance in days determined by NAAT.	—

Countries

Netherlands

Outcome results